Santen Pharmaceutical Co Ltd
Santen Pharmaceutical's Climate Target Data Preview
As of 2024, Santen Pharmaceutical has disclosed 4 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 4 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Santen Pharmaceutical ’s climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target* | Scope 3 - Purchased Goods and Services (Cat. 1) | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2025 |
Absolute-based Target* | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2025 |
Absolute-based Target* | Scope 3 - Purchased Goods and Services (Cat. 1) | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2030 |
Absolute-based Target* | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2030 |
This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Santen Pharmaceutical's Greenhouse Gas Emissions Pathways
As of 2024, Santen Pharmaceutical has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.
Does Santen Pharmaceutical have a target to reduce the emissions from its operations?
As of 2024, Santen Pharmaceutical has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.
Santen Pharmaceutical's most ambitious operational target is to reduce these emissions by 50% by 2030, compared to a baseline of 37,529 Metric Tonnes of CO2 equivalent (mtCO2e) in 2019.
As of 2023, Santen Pharmaceutical is ahead of schedule on its operational emissions reduction target, having achieved 80.42% of the planned reduction.
Santen Pharmaceutical's Operational (Scope 1+2) Emissions Pathway
Does Santen Pharmaceutical have a target to reduce the emissions from its value chain?
As of 2024, Santen Pharmaceutical has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 1 out of the 15 Scope 3 categories defined by the GHG Protocol.
Santen Pharmaceutical's most ambitious value chain target is to reduce these emissions by 15% by 2030, compared to a baseline of 114,586.13 Metric Tonnes of CO2 equivalent (mtCO2e) in 2019.
As of 2023, Santen Pharmaceutical is ahead of schedule on its value chain emissions reduction target, having achieved 70.67% of the planned reduction.